{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T21:37:40Z","timestamp":1778535460950,"version":"3.51.4"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Selective internal radiotherapy with <jats:sup>90<\/jats:sup>Y microspheres is widely used for the treatment of patients with liver cancer. A dosimetric analysis using the dosimetry software Simplicit90y (Boston Scientific, Natick, MA) was conducted to define doses to the tumor and healthy liver, and to determine a threshold tumor dose that could predict progression-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients experiencing hepatocellular carcinoma and treated with <jats:sup>90<\/jats:sup>Y-labeled resin microspheres were included in a retrospective study. The time-to-progression of the target lesions (TTPLs) and overall survival (OS) were evaluated using Kaplan-Meier tests, and this comparison was based on a log-rank test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-four procedures for patients with portal vein thrombosis were realized. Median follow-up was 16 months. A threshold tumor dose of 125 Gy was determined with a sensitivity of 89% and a specificity of 100%. For patients with a tumor dose of less than 125 Gy, the median OS was 7.5 months (95% confidence interval [CI], 5\u201314 months) and the TTPL was 3 months (95% CI, 2\u20136 months) versus 33 months (95% CI, 22\u201339 months) and 23 months (95% CI, 7\u201338 months), respectively, for those with a tumor dose of 125 Gy or more (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0004).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Personalized dosimetry based on <jats:sup>99m<\/jats:sup>Tc-MAA SPECT\/CT is predictive of TTPL and OS in patients with hepatocellular carcinoma. Customized dosimetry software is essential to optimize treatment planning.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003892","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T22:10:54Z","timestamp":1631311854000},"page":"958-964","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Key Role of Personalized Dosimetry in Dose Adjustment for Selective Internal Radiotherapy"],"prefix":"10.1097","volume":"46","author":[{"given":"Celine","family":"Subreville","sequence":"first","affiliation":[{"name":"Radiopharmacie"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Pinaquy","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lapuyade","sequence":"additional","affiliation":[{"name":"Service de Radiologie et d\u2019Imagerie Diagnostique et Interventionnelle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Frederic","family":"Blanc","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9pato-Gastro-Ent\u00e9rologie et Oncologie Digestive, CHU de Bordeaux, Bordeaux, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Bordenave","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Nucl\u00e9aire"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panteleimon","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"Service de Radiologie et d\u2019Imagerie Diagnostique et Interventionnelle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Debordeaux","sequence":"additional","affiliation":[{"name":"Radiopharmacie"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00259-019-04340-5","article-title":"Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","article-title":"A guide to 90Y radioembolization and its dosimetry","volume":"68","year":"2019","journal-title":"Phys Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diii.2020.09.003","article-title":"Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT\/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres","volume":"102","year":"2021","journal-title":"Diagn Interv Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/MNM.0b013e32834a716b","article-title":"Effectiveness of quantitative MAA SPECT\/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres","volume":"32","year":"2011","journal-title":"Nucl Med Commun"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13550-019-0533-6","article-title":"Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy","volume":"9","year":"2019","journal-title":"EJNMMI Res"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00259-019-04465-7","article-title":"Comparative dosimetry between 99mTc-MAA SPECT\/CT and 90Y PET\/CT in primary and metastatic liver tumors","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","year":"2017","journal-title":"Lancet Oncol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.13220","article-title":"High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization","volume":"37","year":"2017","journal-title":"Liver Int"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","article-title":"Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/j.semnuclmed.2019.01.005","article-title":"Dosimetry of Y-90 microspheres utilizing Tc-99m SPECT and Y-90 PET","volume":"49","year":"2019","journal-title":"Semin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","year":"2018","journal-title":"J Hepatol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jvir.2014.01.010","article-title":"Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization","volume":"25","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators","volume":"28","year":"1998","journal-title":"Hepatology"},{"key":"bib16-20250621","first-page":"6","article-title":"A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres","volume":"56","year":"2012","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","article-title":"Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres","volume":"40","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:05:00Z","timestamp":1750536300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003892"}},"subtitle":["Retrospective Study of Patients Treated With 90Y Resin Microspheres"],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003892","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}